Amphastar Pharmaceuticals (AMPH): A High-Quality Value Investment Pick
Amphastar Pharmaceuticals (NASDAQ:AMPH) is currently positioned as a high-quality investment due to its strong profitability, 15.12% return on invested capital (ROIC), and a low price-to-earnings (P/E) ratio of 6.74. The ... Read More